# OnCo record sofie-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sofie-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sofie-biosciences" ;
  schema:name "SOFIE Biosciences"@en ;
  schema:description "SOFIE Biosciences is a US radiopharmacy network running two phase 3 trials of the FAP PET tracer [18F]FAPI-74 in pancreatic and gastro-oesophageal cancer."@en ;
  schema:url <https://onco.cc/companies/sofie-biosciences/>, <https://sofie.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://sofie.com/2026/02/11/sofie-biosciences-announces-first-patient-dosed-in-18ffapi-74-phase-3-study-for-pancreatic-cancer/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/esophageal/> ;
  onco:sections <https://onco.cc/fronts/imaging/>, <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/fapi-pet/>, <https://onco.cc/technologies/pet/> ;
  onco:targets <https://onco.cc/targets/fap/> ;
  onco:institutions <https://onco.cc/institutions/heidelberg-nct/> ;
  onco:trials <https://onco.cc/trials/nct07217704/> .